Not yet recruitingObservationalLast updated Aug 13, 2026

Uromodulin as a Biomarker in Lupus Nephritis

Evaluation of Uromodulin as a Biomarker of Renal Histological Activity/ Chronicity Indices in Lupus Nephritis

Overview

ClinicalTrials.gov ID: NCT07763834
Lead Sponsor: Assiut UniversityOTHER
Brief Summary: Evaluation of Uromodulin as a biomarker of renal histological activity/ Chronicity indices in lupus nephritis
Study Type: Observational

Status

Study Record Dates

NCT03164720Unknown status

SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis

NCT06228222Unknown status

Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.

NCT07505576Not yet recruiting

Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

NCT05695573Completed

Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

NCT07295392Not yet recruiting

Is There Any Prognostic Value of Serum Uromodulin in Sepsis Induced AKI.

NCT03958851Unknown status

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis